ResearcherMoffitt Cancer CenterNo recent work listed
Srinadh Komanduri
Matched on ORCID iD 0000-0002-3666-7654; OpenAlex author ID A5032880093. Sources: ClinicalTrials.gov.
Their work
- Papers
- 5
- Trials
- 1 (principal investigator on 1)
- Grants
- 0
- Labs led
- 0
- Collaborators
- 50
2012: 1 paper, 1 trial · 2013: none · 2014: 1 paper · 2015: 1 paper · 2016: 1 paper · 2017: 1 paper
Papers 5
- Pancreatic Adenocarcinoma, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology. Co-author DOI 10.6004/jnccn.2017.0131↗
- Endosonographers' approach to delivering a diagnosis of pancreatic cancer: obligated but undertrained. Co-author DOI 10.1055/s-0041-109085↗
- Plastic biliary stent patency in patients with locally advanced pancreatic adenocarcinoma receiving downstaging chemotherapy. Co-author DOI 10.1016/j.gie.2014.08.020↗
- Pancreatic adenocarcinoma, version 2.2014: featured updates to the NCCN guidelines. Co-author DOI 10.6004/jnccn.2014.0106↗
- Pancreatic Adenocarcinoma, version 2.2012: featured updates to the NCCN Guidelines. Co-author DOI 10.6004/jnccn.2012.0073↗
Trials 1
- Prospective Trial of EUS-FNA Versus EUS-FNB Using a Novel Core Biopsy Needle Principal investigator NCT01769248↗
Closest collaborators
The 25 strongest of 50 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Albert C. Koong · 3 shared papers, 2012–2017 · strength 0.09
- Paper Pancreatic Adenocarcinoma, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology. DOI 10.6004/jnccn.2017.0131↗
- Paper Pancreatic adenocarcinoma, version 2.2014: featured updates to the NCCN guidelines. DOI 10.6004/jnccn.2014.0106↗
- Paper Pancreatic Adenocarcinoma, version 2.2012: featured updates to the NCCN Guidelines. DOI 10.6004/jnccn.2012.0073↗
- William G. Hawkins · 3 shared papers, 2012–2017 · strength 0.09
- Paper Pancreatic Adenocarcinoma, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology. DOI 10.6004/jnccn.2017.0131↗
- Paper Pancreatic adenocarcinoma, version 2.2014: featured updates to the NCCN guidelines. DOI 10.6004/jnccn.2014.0106↗
- Paper Pancreatic Adenocarcinoma, version 2.2012: featured updates to the NCCN Guidelines. DOI 10.6004/jnccn.2012.0073↗
- Andrew H. Ko · 3 shared papers, 2012–2017 · strength 0.09
- Paper Pancreatic Adenocarcinoma, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology. DOI 10.6004/jnccn.2017.0131↗
- Paper Pancreatic adenocarcinoma, version 2.2014: featured updates to the NCCN guidelines. DOI 10.6004/jnccn.2014.0106↗
- Paper Pancreatic Adenocarcinoma, version 2.2012: featured updates to the NCCN Guidelines. DOI 10.6004/jnccn.2012.0073↗
- Brian G. Czito · 3 shared papers, 2012–2017 · strength 0.09
- Paper Pancreatic Adenocarcinoma, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology. DOI 10.6004/jnccn.2017.0131↗
- Paper Pancreatic adenocarcinoma, version 2.2014: featured updates to the NCCN guidelines. DOI 10.6004/jnccn.2014.0106↗
- Paper Pancreatic Adenocarcinoma, version 2.2012: featured updates to the NCCN Guidelines. DOI 10.6004/jnccn.2012.0073↗
- Robert A. Wolff · 3 shared papers, 2012–2017 · strength 0.09
- Paper Pancreatic Adenocarcinoma, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology. DOI 10.6004/jnccn.2017.0131↗
- Paper Pancreatic adenocarcinoma, version 2.2014: featured updates to the NCCN guidelines. DOI 10.6004/jnccn.2014.0106↗
- Paper Pancreatic Adenocarcinoma, version 2.2012: featured updates to the NCCN Guidelines. DOI 10.6004/jnccn.2012.0073↗
- Joseph M. Herman · 3 shared papers, 2012–2017 · strength 0.09
- Paper Pancreatic Adenocarcinoma, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology. DOI 10.6004/jnccn.2017.0131↗
- Paper Pancreatic adenocarcinoma, version 2.2014: featured updates to the NCCN guidelines. DOI 10.6004/jnccn.2014.0106↗
- Paper Pancreatic Adenocarcinoma, version 2.2012: featured updates to the NCCN Guidelines. DOI 10.6004/jnccn.2012.0073↗
- Stephen W. Behrman · 3 shared papers, 2012–2017 · strength 0.09
- Paper Pancreatic Adenocarcinoma, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology. DOI 10.6004/jnccn.2017.0131↗
- Paper Pancreatic adenocarcinoma, version 2.2014: featured updates to the NCCN guidelines. DOI 10.6004/jnccn.2014.0106↗
- Paper Pancreatic Adenocarcinoma, version 2.2012: featured updates to the NCCN Guidelines. DOI 10.6004/jnccn.2012.0073↗
- Eric K. Nakakura · 3 shared papers, 2012–2017 · strength 0.09
- Paper Pancreatic Adenocarcinoma, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology. DOI 10.6004/jnccn.2017.0131↗
- Paper Pancreatic adenocarcinoma, version 2.2014: featured updates to the NCCN guidelines. DOI 10.6004/jnccn.2014.0106↗
- Paper Pancreatic Adenocarcinoma, version 2.2012: featured updates to the NCCN Guidelines. DOI 10.6004/jnccn.2012.0073↗
- Mokenge Peter Malafa · 3 shared papers, 2012–2017 · strength 0.09
- Paper Pancreatic Adenocarcinoma, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology. DOI 10.6004/jnccn.2017.0131↗
- Paper Pancreatic adenocarcinoma, version 2.2014: featured updates to the NCCN guidelines. DOI 10.6004/jnccn.2014.0106↗
- Paper Pancreatic Adenocarcinoma, version 2.2012: featured updates to the NCCN Guidelines. DOI 10.6004/jnccn.2012.0073↗
- Sarah P. Thayer · 3 shared papers, 2012–2017 · strength 0.09
- Paper Pancreatic Adenocarcinoma, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology. DOI 10.6004/jnccn.2017.0131↗
- Paper Pancreatic adenocarcinoma, version 2.2014: featured updates to the NCCN guidelines. DOI 10.6004/jnccn.2014.0106↗
- Paper Pancreatic Adenocarcinoma, version 2.2012: featured updates to the NCCN Guidelines. DOI 10.6004/jnccn.2012.0073↗
- Brian Matthew Wolpin · 3 shared papers, 2012–2017 · strength 0.09
- Paper Pancreatic Adenocarcinoma, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology. DOI 10.6004/jnccn.2017.0131↗
- Paper Pancreatic adenocarcinoma, version 2.2014: featured updates to the NCCN guidelines. DOI 10.6004/jnccn.2014.0106↗
- Paper Pancreatic Adenocarcinoma, version 2.2012: featured updates to the NCCN Guidelines. DOI 10.6004/jnccn.2012.0073↗
- Margaret A. Tempero · 3 shared papers, 2012–2017 · strength 0.09
- Paper Pancreatic Adenocarcinoma, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology. DOI 10.6004/jnccn.2017.0131↗
- Paper Pancreatic adenocarcinoma, version 2.2014: featured updates to the NCCN guidelines. DOI 10.6004/jnccn.2014.0106↗
- Paper Pancreatic Adenocarcinoma, version 2.2012: featured updates to the NCCN Guidelines. DOI 10.6004/jnccn.2012.0073↗
- Al B. Benson · 3 shared papers, 2012–2017 · strength 0.09
- Paper Pancreatic Adenocarcinoma, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology. DOI 10.6004/jnccn.2017.0131↗
- Paper Pancreatic adenocarcinoma, version 2.2014: featured updates to the NCCN guidelines. DOI 10.6004/jnccn.2014.0106↗
- Paper Pancreatic Adenocarcinoma, version 2.2012: featured updates to the NCCN Guidelines. DOI 10.6004/jnccn.2012.0073↗
- Laurie Keefer · 1 shared paper, 2016 · strength 0.08
- Sushanth Reddy · 2 shared papers, 2014–2017 · strength 0.07
- Andrew M. Lowy · 2 shared papers, 2014–2017 · strength 0.07
- Vincent M. Chung · 2 shared papers, 2014–2017 · strength 0.07
- Colin D. Weekes · 2 shared papers, 2014–2017 · strength 0.07
- Elena Gabriela Chiorean · 2 shared papers, 2014–2017 · strength 0.07
- Deborah A. Freedman-Cass · 2 shared papers, 2012–2014 · strength 0.05
- Martha B. Pitman · 2 shared papers, 2012–2014 · strength 0.05
- John Parker Hoffman · 2 shared papers, 2012–2014 · strength 0.05
- Peter Muscarella · 2 shared papers, 2012–2014 · strength 0.05
- Sean J. Mulvihill · 2 shared papers, 2012–2014 · strength 0.05
- Nipun B. Merchant · 2 shared papers, 2012–2014 · strength 0.05
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.